Literature DB >> 30928994

Intact responses to non-drug rewards in long-term opioid maintenance treatment.

Marie Eikemo1,2,3, Philipp P Lobmaier4,5, Mads L Pedersen6,7, Nikolaj Kunøe4, Anna Maria Matziorinis6, Siri Leknes6,7, Monica Sarfi4.   

Abstract

Disruption of non-drug reward processing in addiction could stem from long-term drug use, addiction-related psychosocial stress, or a combination of these. It remains unclear whether long-term opioid maintenance treatment (OMT) disrupts reward processing. Here, we measured subjective and objective reward responsiveness in 26 previously heroin-addicted mothers in >7 years stable OMT with minimal psychosocial stress and illicit drug use. The comparison group was 30 healthy age-matched mothers (COMP). Objective reward responsiveness was assessed in a two-alternative forced-choice task with skewed rewards. Results were also compared to performance from an additional 968 healthy volunteers (meta-analytic approach). We further compared subprocesses of reward-based decisions across groups using computational modelling with a Bayesian drift diffusion model of decision making. Self-reported responsiveness to non-drug rewards was high for both groups (means: OMT = 6.59, COMP = 6.67, p = 0.84, BF10 = 0.29), yielding moderate evidence against subjective anhedonia in this OMT group. Importantly, the mothers in OMT also displayed robust reward responsiveness in the behavioral task (t19 = 2.72, p = 0.013, BF10 = 3.98; d = 0.61). Monetary reward changed their task behavior to the same extent as the local comparison group (reward bias OMT = 0.12, COMP = 0.12, p = 0.96, BF10 = 0.18) and in line with data from 968 healthy controls previously tested. Computational modelling revealed that long-term OMT did not even change decision subprocesses underpinning reward behavior. We conclude that reduced sensitivity to rewards and anhedonia are not necessary consequences of prolonged opioid use.

Entities:  

Mesh:

Year:  2019        PMID: 30928994      PMCID: PMC6785711          DOI: 10.1038/s41386-019-0377-9

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  78 in total

1.  Quality of life under maintenance treatment with heroin versus methadone in patients with opioid dependence.

Authors:  A Karow; J Reimer; I Schäfer; M Krausz; C Haasen; U Verthein
Journal:  Drug Alcohol Depend       Date:  2010-08-21       Impact factor: 4.492

2.  Neurobiological substrates of cue-elicited craving and anhedonia in recently abstinent opioid-dependent males.

Authors:  Fleur Zijlstra; Dick J Veltman; Jan Booij; Wim van den Brink; Ingmar H A Franken
Journal:  Drug Alcohol Depend       Date:  2008-09-26       Impact factor: 4.492

3.  Shortened time horizons and insensitivity to future consequences in heroin addicts.

Authors:  N M Petry; W K Bickel; M Arnett
Journal:  Addiction       Date:  1998-05       Impact factor: 6.526

4.  Measuring hedonic capacity in depression: a psychometric analysis of three anhedonia scales.

Authors:  Adam M Leventhal; Gregory S Chasson; Evelina Tapia; Elizabeth K Miller; Jeremy W Pettit
Journal:  J Clin Psychol       Date:  2006-12

Review 5.  Medical complications in methadone patients.

Authors:  M J Kreek
Journal:  Ann N Y Acad Sci       Date:  1978       Impact factor: 5.691

Review 6.  Neurobiology of addiction: a neurocircuitry analysis.

Authors:  George F Koob; Nora D Volkow
Journal:  Lancet Psychiatry       Date:  2016-08       Impact factor: 27.083

7.  The assessment of anhedonia in clinical and non-clinical populations: further validation of the Snaith-Hamilton Pleasure Scale (SHAPS).

Authors:  Ingmar H A Franken; Eric Rassin; Peter Muris
Journal:  J Affect Disord       Date:  2006-09-20       Impact factor: 4.839

8.  Changes in reward-induced brain activation in opiate addicts.

Authors:  C Martin-Soelch; A F Chevalley; G Künig; J Missimer; S Magyar; A Mino; W Schultz; K L Leenders
Journal:  Eur J Neurosci       Date:  2001-10       Impact factor: 3.386

9.  Decision-making impairments in the context of intact reward sensitivity in schizophrenia.

Authors:  Erin A Heerey; Kimberly R Bell-Warren; James M Gold
Journal:  Biol Psychiatry       Date:  2008-04-02       Impact factor: 13.382

10.  Anhedonia and substance dependence: clinical correlates and treatment options.

Authors:  Daniele Stavros Hatzigiakoumis; Giovanni Martinotti; Massimo Di Giannantonio; Luigi Janiri
Journal:  Front Psychiatry       Date:  2011-03-17       Impact factor: 4.157

View more
  3 in total

1.  I feel good? Anhedonia might not mean "without pleasure" for people treated for opioid use disorder.

Authors:  Samuel W Stull; Jeremiah W Bertz; Leigh V Panlilio; William J Kowalczyk; Karran A Phillips; Landhing M Moran; Jia-Ling Lin; Massoud Vahabzadeh; Patrick H Finan; Kenzie L Preston; David H Epstein
Journal:  J Abnorm Psychol       Date:  2021-07

2.  Reward Responsiveness in Patients with Opioid Use Disorder on Opioid Agonist Treatment: Role of Comorbid Chronic Pain.

Authors:  Patrick H Finan; Janelle Letzen; David H Epstein; Chung Jung Mun; Samuel Stull; William J Kowalczyk; Daniel Agage; Karran A Phillips; Diego A Pizzagalli; Kenzie L Preston
Journal:  Pain Med       Date:  2021-09-08       Impact factor: 3.750

Review 3.  The Role of Mu-Opioids for Reward and Threat Processing in Humans: Bridging the Gap from Preclinical to Clinical Opioid Drug Studies.

Authors:  Isabell M Meier; Marie Eikemo; Siri Leknes
Journal:  Curr Addict Rep       Date:  2021-04-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.